Estudio sobre la efectividad y tolerancia comparando tratamiento profiláctico y tratamiento anticipado para la prevención de la enfermedad por CMV en pacientes …

I López Jiménez - Proyecto de investigación:, 2020 - digitum.um.es
El citomegalovirus (CMV) es el patógeno viral más importante y el que con mayor
frecuencia complica el trasplante. Actualmente, la controversia fundamental en relación a su …

Cytomegalovirus infection in transplantation

RR Razonable - Emerging Infections 9, 2010 - Wiley Online Library
Cytomegalovirus (CMV) latency exists in numerous cells, including leukocytes, endothelial
cells, and epithelial cells, among others, which are important reservoirs for the transmission …

Eficacia y seguridad de ganciclovir y valganciclovir en el manejo de la infección por citomegalovirus en el trasplante de órgano sólido

M Serrano-Alonso - 2019 - dadun.unav.edu
El presente trabajo, titulado “Eficacia y seguridad de ganciclovir y valganciclovir en el
manejo de la infección por citomegalovirus en el trasplante de órgano sólido”, presentado …

Analysis of cytomegalovirus UL97 drug resistance mutations in patients receiving Ganciclovir

NP Nkosi - 2018 - open.uct.ac.za
Introduction: Cytomegalovirus (CMV) drug resistance mutations, because of the widespread
use of ganciclovir, have been widely reported in international literature, particularly in the …

[HTML][HTML] Cytomegalovirová a polyomavirová infekce po transplantaci ledviny

J Machová, T Reischig - Vnitřní lékařství, 2017 - casopisvnitrnilekarstvi.cz
Virové infekce patří mezi jedny z nejčastějších infekčních komplikací postihující příjemce
transplantovaných orgánů. V důsledku imunosupresivní terapie, která dominantně ovlivňuje …

Is drug repurposing the answer for cytomegalovirus treatment or prevention?

R Arav-Boger - Future Virology, 2017 - Taylor & Francis
Medical progress has placed cytomegalovirus (CMV) as one of the most important viral
pathogens for which treatment is limited and a vaccine is not yet available. The limited …

Treatment of human cytomegalovirus by modulating Wnt

R Boger - US Patent 9,549,914, 2017 - Google Patents
The present invention relates to the field of virology. More specifically, the present invention
provides methods and compositions useful for treating human cytomegalovirus using Wnt …

[PDF][PDF] The Prevention and Management of CMV Disease after Solid Organ Transplantation

T Edition - 2015 - bts.org.uk
These Guidelines are guides to best practice which inevitably change with the passage of
time. All practitioners need to undertake clinical care on an individual basis and keep …

[PDF][PDF] Drug Resistance due to Mutation in UL 97 and Certain Other Specific Genes in Cytomegalovirus Strains: An Overview

S Kumar, S Mishra - academia.edu
The study of human cytomegalovirus (HCMV) antiviral drug resistance has enhanced
knowledge of the virological targets and the mechanisms of antiviral activity. The currently …

[引用][C] Матеріали та методи дослідження

V Dikusarov, K Kulikovska, I Byrchak